NEAT Evaluates TVA Medical's everlinQ System for Creating Endovascular Arteriovenous Fistula
November 3, 2015—Charmaine E. Lok, MD, presented preliminary results from the Novel Endovascular Access Trial (NEAT) during the second of two Late-Breaking Trials sessions at VIVA 15, the 13th annual Vascular InterVentional Advances meeting. The meeting, which is sponsored by VIVA Physicians, Inc., is being held November 2–5, 2015, at the Wynn Las Vegas in Las Vegas, Nevada. The session moderators are Michael R. Jaff, DO, and Krishna Rocha-Singh, MD.